Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Randomised Study of Induction Chemotherapy Followed by Capecitabine (+/-Nelfinavir) With High or Standard Dose Radiotherapy for Locally Advanced Non-metastatic Pancreatic Cancer

NCT02024009 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT02024009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02024009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Randomised Study of Induction Chemotherapy Followed by Capecitabine (+/-Nelfinavir) With High or Standard Dose Radiotherapy for Locally Advanced Non-metastatic Pancreatic Cancer
Lead sponsor
University of Oxford
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2016
Completion date
June 23, 2021
Enrollment
159 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic neoplasms (locally advanced non-metastatic)